Anandkumar R. Tengli, B.M. Gurupadayya, Neeraj Soni
{"title":"反相高效液相色谱法同时测定片剂中氢氯噻嗪、氨氯地平和氯沙坦的含量","authors":"Anandkumar R. Tengli, B.M. Gurupadayya, Neeraj Soni","doi":"10.1016/j.ijcas.2013.03.003","DOIUrl":null,"url":null,"abstract":"<div><p>A simple, sensitive and specific liquid chromatographic method with UV detection (230 nm) was developed for the simultaneous estimation of hydrochlorothiazide, amlodipine and losartan in tablet dosage form and telmisartan as an internal standard. Separation was achieved with a phenomenex luna 5μ CN 100R, 250 × 4.60 mm 5 micron size column, ambient temperature with a low pressure gradient mode with mobile phase containing acetonitrile, water and 0.4% of potassium dihydrogen phosphate buffer pH 2.7 adjusted with orthophosphoric acid (45:35:20). The flow rate was 1 mL min<sup>−1</sup> and eluent was monitored at 230 nm. The selected chromatographic conditions were found to effectively separate hydrochlorothiazide, amlodipine and losartan with retention time of 3.9, 4.9 and 5.8 min respectively. The linearity range of hydrochlorothiazide, amlodipine and losartan found in the range of 12.5–62.5 μg ml<sup>−1</sup>, 2.5–12.5 μg ml<sup>−1</sup> and 50–250 μg ml<sup>−1</sup> respectively. The proposed method was found to be accurate, precise, reproducible and specific and it can also be used for routine quality-control analysis of these drugs in combination tablets.</p></div>","PeriodicalId":100693,"journal":{"name":"International Journal of Chemical and Analytical Science","volume":"4 1","pages":"Pages 33-38"},"PeriodicalIF":0.0000,"publicationDate":"2013-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ijcas.2013.03.003","citationCount":"29","resultStr":"{\"title\":\"Simultaneous estimation of hydrochlorothiazide, amlodipine, and losartan in tablet dosage form by RP-HPLC\",\"authors\":\"Anandkumar R. Tengli, B.M. Gurupadayya, Neeraj Soni\",\"doi\":\"10.1016/j.ijcas.2013.03.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A simple, sensitive and specific liquid chromatographic method with UV detection (230 nm) was developed for the simultaneous estimation of hydrochlorothiazide, amlodipine and losartan in tablet dosage form and telmisartan as an internal standard. Separation was achieved with a phenomenex luna 5μ CN 100R, 250 × 4.60 mm 5 micron size column, ambient temperature with a low pressure gradient mode with mobile phase containing acetonitrile, water and 0.4% of potassium dihydrogen phosphate buffer pH 2.7 adjusted with orthophosphoric acid (45:35:20). The flow rate was 1 mL min<sup>−1</sup> and eluent was monitored at 230 nm. The selected chromatographic conditions were found to effectively separate hydrochlorothiazide, amlodipine and losartan with retention time of 3.9, 4.9 and 5.8 min respectively. The linearity range of hydrochlorothiazide, amlodipine and losartan found in the range of 12.5–62.5 μg ml<sup>−1</sup>, 2.5–12.5 μg ml<sup>−1</sup> and 50–250 μg ml<sup>−1</sup> respectively. The proposed method was found to be accurate, precise, reproducible and specific and it can also be used for routine quality-control analysis of these drugs in combination tablets.</p></div>\",\"PeriodicalId\":100693,\"journal\":{\"name\":\"International Journal of Chemical and Analytical Science\",\"volume\":\"4 1\",\"pages\":\"Pages 33-38\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ijcas.2013.03.003\",\"citationCount\":\"29\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Chemical and Analytical Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0976120913000053\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Chemical and Analytical Science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0976120913000053","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 29
摘要
建立了以替米沙坦为内标,同时测定片剂剂型中氢氯噻嗪、氨氯地平和氯沙坦含量的简便、灵敏、特异的紫外检测(230 nm)液相色谱方法。色谱柱为phenomenex luna 5μ CN 100R,柱尺寸为250 × 4.60 mm,柱温为低压梯度模式,流动相为乙腈、水和0.4%磷酸二氢钾缓冲液,缓冲液pH为2.7,正磷酸调节(45:35:20)。流速为1 mL min - 1,在230 nm处监测洗脱液。所选色谱条件能有效分离氢氯噻嗪、氨氯地平和氯沙坦,保留时间分别为3.9、4.9和5.8 min。氢氯噻嗪、氨氯地平和氯沙坦分别在12.5 ~ 62.5 μg ml−1、2.5 ~ 12.5 μg ml−1和50 ~ 250 μg ml−1范围内呈线性关系。该方法准确、精密度高、重现性好、专属性好,可用于复方片剂的常规质量控制分析。
Simultaneous estimation of hydrochlorothiazide, amlodipine, and losartan in tablet dosage form by RP-HPLC
A simple, sensitive and specific liquid chromatographic method with UV detection (230 nm) was developed for the simultaneous estimation of hydrochlorothiazide, amlodipine and losartan in tablet dosage form and telmisartan as an internal standard. Separation was achieved with a phenomenex luna 5μ CN 100R, 250 × 4.60 mm 5 micron size column, ambient temperature with a low pressure gradient mode with mobile phase containing acetonitrile, water and 0.4% of potassium dihydrogen phosphate buffer pH 2.7 adjusted with orthophosphoric acid (45:35:20). The flow rate was 1 mL min−1 and eluent was monitored at 230 nm. The selected chromatographic conditions were found to effectively separate hydrochlorothiazide, amlodipine and losartan with retention time of 3.9, 4.9 and 5.8 min respectively. The linearity range of hydrochlorothiazide, amlodipine and losartan found in the range of 12.5–62.5 μg ml−1, 2.5–12.5 μg ml−1 and 50–250 μg ml−1 respectively. The proposed method was found to be accurate, precise, reproducible and specific and it can also be used for routine quality-control analysis of these drugs in combination tablets.